Literature DB >> 27028062

Hyperglycemia Enhances the Production of Amyloid β1-42 in the Lenses of Otsuka Long-Evans Tokushima Fatty Rats, a Model of Human Type 2 Diabetes.

Noriaki Nagai1, Yoshimasa Ito1, Hiroshi Sasaki2.   

Abstract

PURPOSE: It has been reported that the accumulation of amyloid β1-42 (Aβ1-42) in human lenses can cause some forms of lens opacification. However, the factors leading to changes in the accumulation of Aβ in the lens remain obscure. In this study, we investigate the effect of hyperglycemia on Aβ1-42 accumulation in lenses.
METHODS: Otsuka Long-Evans Tokushima Fatty (OLETF) rats and the human lens epithelial cell line SRA 01/04 (HLE cells) were used. The expression of mRNA was determined using a quantitative real-time RT-PCR method; Aβ1-42 levels were analyzed by an ELISA method.
RESULTS: Otsuka Long-Evans Tokushima Fatty rats at more than 20 weeks of age develop diabetes mellitus with hyperglycemia. Additionally, the levels of the mRNAs for Aβ1-42, amyloid precursor proteins (APP), β-(BACE1), and·γ-secretase (PS) rise in the lenses of OLETF rats with age; high Aβ1-42 levels are observed in the lens capsule-epithelium and cortex. The enhanced expression of the genes for APP, BACE1, and PS in the lenses of OLETF rats is prevented by food restriction (25 g/d/rat). When the effect of glucose levels on the production of Aβ1-42 was investigated in the human lens epithelial cell line SRA 01/04 (HLE cells), the mRNA levels for APP, BACE1, and PS, as well as Aβ1-42 protein levels, were significantly higher under high glucose conditions (20 mM) than under normal glucose conditions (5.6 mM).
CONCLUSIONS: High glucose leads to the increased expression of genes related to Aβ production, resulting in the accumulation of Aβ in the lens.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27028062     DOI: 10.1167/iovs.15-19026

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Proteomic profile of the lens in a streptozotocin-induced diabetic rat model using shotgun proteomics.

Authors:  Noriaki Nagai; Tetsushi Yamamoto; Kuniko Mitamura; Atsushi Taga
Journal:  Biomed Rep       Date:  2017-09-22

2.  Urolithin A suppresses high glucose-induced neuronal amyloidogenesis by modulating TGM2-dependent ER-mitochondria contacts and calcium homeostasis.

Authors:  Hyun Jik Lee; Young Hyun Jung; Gee Euhn Choi; Jun Sung Kim; Chang Woo Chae; Jae Ryong Lim; Seo Yihl Kim; Jee Hyeon Yoon; Ji Hyeon Cho; Sei-Jung Lee; Ho Jae Han
Journal:  Cell Death Differ       Date:  2020-07-23       Impact factor: 15.828

3.  Ionizing radiation response of primary normal human lens epithelial cells.

Authors:  Nobuyuki Hamada
Journal:  PLoS One       Date:  2017-07-26       Impact factor: 3.240

4.  Ferulic Acid Suppresses Amyloid β Production in the Human Lens Epithelial Cell Stimulated with Hydrogen Peroxide.

Authors:  Noriaki Nagai; Sachiyo Kotani; Yu Mano; Akina Ueno; Yoshimasa Ito; Toshio Kitaba; Takumi Takata; Noriko Fujii
Journal:  Biomed Res Int       Date:  2017-03-20       Impact factor: 3.411

5.  γ-Secretase Modulatory Proteins: The Guiding Hand Behind the Running Scissors.

Authors:  Eitan Wong; Georgia R Frost; Yue-Ming Li
Journal:  Front Aging Neurosci       Date:  2020-12-02       Impact factor: 5.750

6.  Therapeutic Effect of Cilostazol Ophthalmic Nanodispersions on Retinal Dysfunction in Streptozotocin-Induced Diabetic Rats.

Authors:  Noriaki Nagai; Saori Deguchi; Hiroko Otake; Noriko Hiramatsu; Naoki Yamamoto
Journal:  Int J Mol Sci       Date:  2017-09-14       Impact factor: 5.923

7.  A Proteomic Approach for Understanding the Mechanisms of Delayed Corneal Wound Healing in Diabetic Keratopathy Using Diabetic Model Rat.

Authors:  Tetsushi Yamamoto; Hiroko Otake; Noriko Hiramatsu; Naoki Yamamoto; Atsushi Taga; Noriaki Nagai
Journal:  Int J Mol Sci       Date:  2018-11-18       Impact factor: 5.923

8.  Enhancement of Amyloid β1-43 Production in the Lens Epithelium of Japanese Type 2 Diabetic Patients.

Authors:  Yu Mano; Hiroko Otake; Teppei Shibata; Eri Kubo; Hiroshi Sasaki; Noriaki Nagai
Journal:  Biomedicines       Date:  2020-04-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.